Compare Heron Therapeutics Inc (HRTX) vs KeyCorp (KEY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs KeyCorp — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while KeyCorp trades at $23.55 (market cap $25.17B). The key difference: KeyCorp is far larger — about 275.2× Heron Therapeutics Inc's market cap, and KeyCorp pays a 3.52% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | KEY | |
|---|---|---|
Market Cap | $91.46M | $25.17B |
Sector | Health | Financials |
52-Week High | $1.96 | $23.99 |
52-Week Low | $0.39 | $16.78 |
Enterprise Value | $189.36M | — |
Dividend Yield | — | 3.52% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →
